Shandong Buchang Pharmaceuticals Co., Ltd.
SSE:603858.SS
16.84 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,784.947 | 2,491.391 | 3,082.731 | 2,758.039 | 2,599.846 | 3,208.091 | 3,025.545 | 3,442.727 | 3,514.95 | 3,646.532 | 4,206.623 | 3,897.599 | 3,200.498 | 4,385.524 | 3,991.177 | 4,035.179 | 3,350.8 | 4,762.568 | 4,208.693 | 4,396.344 | 2,639.11 | 4,013.099 | 3,837.605 | 3,521.638 | 2,883.113 | 4,378.404 | 3,538.346 | 3,317.217 | 2,430.785 | 4,418.326 | 3,694.151 | 3,322.868 | 2,428.574 | 3,318.619 | 3,851.495 | 3,149.136 | 2,001.633 | 3,880.632 |
| Cost of Revenue
| 1,063.955 | 776.916 | 1,315.498 | 1,326.785 | 1,091.518 | 1,156.98 | 949.99 | 1,116.804 | 1,061.921 | 836.994 | 1,092.369 | 1,420.809 | 882.338 | 1,160.662 | 1,029.087 | 1,077.132 | 865.915 | 1,144.356 | 911.997 | 1,078.314 | 606.344 | 682.678 | 653.978 | 541.492 | 510.998 | 756.243 | 572.37 | 543.435 | 479.722 | 768.773 | 662.499 | 565.133 | 451.243 | 592.129 | 603.184 | 534.195 | 343.756 | 680.595 |
| Gross Profit
| 1,720.992 | 1,714.475 | 1,767.233 | 1,431.254 | 1,508.327 | 2,051.111 | 2,075.555 | 2,325.923 | 2,453.029 | 2,809.538 | 3,114.254 | 2,476.79 | 2,318.16 | 3,224.862 | 2,962.09 | 2,958.047 | 2,484.885 | 3,618.212 | 3,296.696 | 3,318.03 | 2,032.766 | 3,330.421 | 3,183.627 | 2,980.146 | 2,372.115 | 3,622.161 | 2,965.976 | 2,773.783 | 1,951.062 | 3,649.552 | 3,031.652 | 2,757.735 | 1,977.331 | 2,726.49 | 3,248.311 | 2,614.941 | 1,657.877 | 3,200.037 |
| Gross Profit Ratio
| 0.618 | 0.688 | 0.573 | 0.519 | 0.58 | 0.639 | 0.686 | 0.676 | 0.698 | 0.77 | 0.74 | 0.635 | 0.724 | 0.735 | 0.742 | 0.733 | 0.742 | 0.76 | 0.783 | 0.755 | 0.77 | 0.83 | 0.83 | 0.846 | 0.823 | 0.827 | 0.838 | 0.836 | 0.803 | 0.826 | 0.821 | 0.83 | 0.814 | 0.822 | 0.843 | 0.83 | 0.828 | 0.825 |
| Reseach & Development Expenses
| 45.146 | 165.207 | 54.792 | 72.318 | 46.021 | 180.342 | 50.707 | 63.465 | 36.838 | 48.413 | 136.155 | 53.488 | 46.067 | 147.953 | 89.613 | 93.255 | 77.782 | 279.686 | 80.321 | 125.567 | 47.842 | 324.769 | 64.574 | 58.644 | 57.374 | 130.076 | 145.832 | 114.911 | 89.419 | 739.759 | 103.371 | 156.445 | 0 | 458.916 | 0 | 143.743 | 0 | 200.606 |
| General & Administrative Expenses
| 192.314 | -286.74 | 570.214 | -110.752 | 204.646 | -366.99 | 588.8 | -74.913 | 223.84 | -409.556 | 524.498 | -101.289 | 228.036 | -408.323 | 548.474 | -89.953 | 209.599 | -299.944 | 203.282 | -58.352 | 172.209 | -195.474 | 185.4 | -82.852 | 207.359 | -241.761 | 156.011 | -103.814 | 225.023 | -443.764 | 230.579 | -122.268 | 227.615 | -389.768 | 216.188 | -80.465 | 171.396 | -273.453 |
| Selling & Marketing Expenses
| 1,090.082 | 810.471 | 1,329.447 | 1,005.543 | 1,062.869 | 1,528.639 | 1,461.335 | 1,666.971 | 1,711.897 | 2,006.637 | 2,146.54 | 1,693.223 | 1,637.806 | 2,510.58 | 2,067.389 | 2,070.924 | 1,651.476 | 2,414.471 | 2,275.295 | 2,293.406 | 1,390.139 | 2,031.75 | 2,210.496 | 2,131.713 | 1,706.659 | 2,511.496 | 2,081.645 | 1,989.591 | 1,453.055 | 2,726.862 | 2,180.091 | 1,961.684 | 1,418.427 | 1,787.281 | 2,104.947 | 1,716.239 | 1,241.788 | 2,149.565 |
| SG&A
| 1,282.397 | 523.731 | 1,396.203 | 1,125.168 | 1,241.56 | 1,753.954 | 2,050.135 | 1,592.058 | 1,935.736 | 1,597.081 | 2,671.038 | 1,591.934 | 1,865.842 | 2,102.257 | 2,615.864 | 1,980.97 | 1,861.075 | 2,114.527 | 2,478.577 | 2,235.055 | 1,562.348 | 1,836.276 | 2,395.896 | 2,048.861 | 1,914.018 | 2,269.735 | 2,237.657 | 1,885.777 | 1,678.078 | 2,283.098 | 2,410.67 | 1,839.416 | 1,646.041 | 1,397.513 | 2,321.135 | 1,635.774 | 1,413.184 | 1,876.112 |
| Other Expenses
| 10.635 | 1,867.202 | -375.933 | -22.163 | -0.128 | -100.95 | -26.687 | -8.965 | -44.698 | 877.073 | -277.854 | 341.089 | -144.477 | -14.089 | -10.696 | -7.552 | -1.669 | -4.712 | 0.451 | 1.101 | -1.512 | -1.794 | -7.212 | -5.485 | 0.253 | 8.726 | -7.088 | -9.351 | -8.03 | 220.642 | -7.123 | -35.98 | 24.708 | -2.892 | 63.062 | 15.225 | 57.161 | 134.182 |
| Operating Expenses
| 1,338.177 | 2,556.139 | 1,581.901 | 1,219.65 | 1,287.709 | 2,035.246 | 1,814.349 | 1,955.901 | 1,927.876 | 2,522.566 | 2,529.34 | 1,986.511 | 1,767.431 | 2,969.837 | 2,434.591 | 2,283.084 | 1,976.928 | 2,999.001 | 2,606.11 | 2,549.864 | 1,644.702 | 2,623.077 | 2,484.645 | 2,279.142 | 2,021.334 | 2,801.962 | 2,340.27 | 2,185.54 | 1,671.704 | 3,249.288 | 2,473.536 | 2,202.678 | 1,695.11 | 2,223.678 | 2,400.886 | 2,010.128 | 1,454.859 | 2,488.801 |
| Operating Income
| 382.815 | -841.664 | 185.331 | 211.604 | 220.618 | 15.865 | 243.204 | 358.708 | 518.684 | -2,925.714 | 554.014 | 464.395 | 530.712 | 109.447 | 478.652 | 684.923 | 474.687 | 605.316 | 666.712 | 728.05 | 365.287 | 652.77 | 681.482 | 724.771 | 369.929 | 786.185 | 604.007 | 598.722 | 281.431 | 386.299 | 538.407 | 570.418 | 262.953 | 581.078 | 729.953 | 478.05 | 183.705 | 643.202 |
| Operating Income Ratio
| 0.137 | -0.338 | 0.06 | 0.077 | 0.085 | 0.005 | 0.08 | 0.104 | 0.148 | -0.802 | 0.132 | 0.119 | 0.166 | 0.025 | 0.12 | 0.17 | 0.142 | 0.127 | 0.158 | 0.166 | 0.138 | 0.163 | 0.178 | 0.206 | 0.128 | 0.18 | 0.171 | 0.18 | 0.116 | 0.087 | 0.146 | 0.172 | 0.108 | 0.175 | 0.19 | 0.152 | 0.092 | 0.166 |
| Total Other Income Expenses Net
| -6.686 | -25.473 | -87.458 | -2.88 | -0.775 | -708.164 | -22.763 | -14.385 | -6.893 | -0.623 | -2.261 | -2.438 | -4.607 | -14.089 | -10.696 | -7.552 | -1.669 | -4.712 | 0.451 | -3.234 | -1.512 | -1.794 | -7.212 | -5.485 | 0.253 | 8.726 | -7.088 | -9.351 | -8.03 | 176.171 | -8.914 | -35.93 | 24.55 | -2.68 | 63.033 | 14.943 | 57.042 | 132.794 |
| Income Before Tax
| 376.129 | -867.137 | 97.873 | 186.585 | 212.354 | -692.298 | 216.516 | 349.743 | 514.543 | -2,926.337 | 551.753 | 461.956 | 526.105 | 95.358 | 467.956 | 677.371 | 473.018 | 600.604 | 667.163 | 729.152 | 363.774 | 650.975 | 674.27 | 719.286 | 370.182 | 794.911 | 596.918 | 589.37 | 273.401 | 608.84 | 529.492 | 534.488 | 287.503 | 577.889 | 792.986 | 492.993 | 240.746 | 775.996 |
| Income Before Tax Ratio
| 0.135 | -0.348 | 0.032 | 0.068 | 0.082 | -0.216 | 0.072 | 0.102 | 0.146 | -0.802 | 0.131 | 0.119 | 0.164 | 0.022 | 0.117 | 0.168 | 0.141 | 0.126 | 0.159 | 0.166 | 0.138 | 0.162 | 0.176 | 0.204 | 0.128 | 0.182 | 0.169 | 0.178 | 0.112 | 0.138 | 0.143 | 0.161 | 0.118 | 0.174 | 0.206 | 0.157 | 0.12 | 0.2 |
| Income Tax Expense
| 86.238 | 53.133 | 61.132 | 100.133 | 122.704 | -6.877 | 68.864 | 102.101 | 78.604 | 16.039 | 111.298 | 88.958 | 115.299 | 98.106 | 153.224 | 146.182 | 80.776 | 152.792 | 175.722 | 128.337 | 60.7 | 49.229 | 118.675 | 198.609 | 84.973 | 119.537 | 80.03 | 78.896 | 68.644 | 99.819 | 77.093 | 77.552 | 66.922 | 65.936 | 139.71 | 80.751 | 48.307 | 132.922 |
| Net Income
| 307.261 | -866.661 | 81.447 | 117.401 | 114.016 | -606.17 | 179.005 | 290.869 | 455.269 | -2,942.376 | 448.482 | 388.531 | 429.845 | 15.321 | 327.875 | 540.192 | 405.864 | 465.139 | 494.244 | 597.233 | 304.278 | 596.959 | 550.248 | 514.616 | 284.175 | 672.765 | 514.725 | 494.676 | 206.24 | 507.869 | 452.018 | 455.683 | 222.382 | 510.867 | 653.271 | 412.36 | 192.867 | 644.501 |
| Net Income Ratio
| 0.11 | -0.348 | 0.026 | 0.043 | 0.044 | -0.189 | 0.059 | 0.084 | 0.13 | -0.807 | 0.107 | 0.1 | 0.134 | 0.003 | 0.082 | 0.134 | 0.121 | 0.098 | 0.117 | 0.136 | 0.115 | 0.149 | 0.143 | 0.146 | 0.099 | 0.154 | 0.145 | 0.149 | 0.085 | 0.115 | 0.122 | 0.137 | 0.092 | 0.154 | 0.17 | 0.131 | 0.096 | 0.166 |
| EPS
| 0.29 | -0.817 | 0.076 | 0.11 | 0.1 | -0.55 | 0.16 | 0.26 | 0.41 | -2.66 | 0.41 | 0.35 | 0.39 | 0.014 | 0.3 | 0.49 | 0.37 | 0.42 | 0.45 | 0.54 | 0.28 | 0.54 | 0.5 | 0.45 | 0.25 | 0.35 | 0.45 | 0.43 | 0.18 | 0.44 | 0.51 | 0.4 | 0.19 | 0.49 | 0.63 | 0.4 | 0.19 | 0.62 |
| EPS Diluted
| 0.29 | -0.817 | 0.076 | 0.11 | 0.1 | -0.55 | 0.16 | 0.26 | 0.41 | -2.66 | 0.41 | 0.35 | 0.39 | 0.014 | 0.3 | 0.49 | 0.37 | 0.42 | 0.45 | 0.54 | 0.28 | 0.54 | 0.5 | 0.45 | 0.25 | 0.35 | 0.45 | 0.43 | 0.18 | 0.44 | 0.51 | 0.4 | 0.19 | 0.49 | 0.63 | 0.4 | 0.19 | 0.62 |
| EBITDA
| 404.788 | -832.32 | 130.086 | 373.308 | 347.705 | 167.205 | 404.098 | 518.934 | 686.404 | 284.575 | 700.18 | 620.817 | 711.643 | 244.429 | 641.674 | 793.622 | 645.202 | 739.561 | 784.133 | 770.706 | 499.709 | 813.718 | 783.175 | 821.717 | 463.271 | 819.248 | 624.416 | 623.202 | 288.507 | 654.489 | 577.912 | 585.839 | 282.22 | 680.755 | 887.589 | 609.953 | 203.018 | 784.993 |
| EBITDA Ratio
| 0.145 | -0.334 | 0.042 | 0.135 | 0.134 | 0.052 | 0.134 | 0.151 | 0.195 | 0.078 | 0.166 | 0.159 | 0.222 | 0.056 | 0.161 | 0.197 | 0.193 | 0.155 | 0.186 | 0.175 | 0.189 | 0.203 | 0.204 | 0.233 | 0.161 | 0.187 | 0.176 | 0.188 | 0.119 | 0.148 | 0.156 | 0.176 | 0.116 | 0.205 | 0.23 | 0.194 | 0.101 | 0.202 |